APA (7th ed.) Citation

T, S., JA, V. H., X, G., J, Y., S, U., WC, L., . . . JR, A. (2024). Isoform-selective TGF-β3 inhibition for systemic sclerosis. Med (New York, N.Y.), 5(2), 132. https://doi.org/10.1016/j.medj.2023.12.011

Chicago Style (17th ed.) Citation

T, Sun, et al. "Isoform-selective TGF-β3 Inhibition for Systemic Sclerosis." Med (New York, N.Y.) 5, no. 2 (2024): 132. https://doi.org/10.1016/j.medj.2023.12.011.

MLA (9th ed.) Citation

T, Sun, et al. "Isoform-selective TGF-β3 Inhibition for Systemic Sclerosis." Med (New York, N.Y.), vol. 5, no. 2, 2024, p. 132, https://doi.org/10.1016/j.medj.2023.12.011.